Nang Kwong Chemo-Pharmaceutical Co., Ltd.: Q1 2026 EPS 0.32 NTD
Nang Kwong Chemo-Pharmaceutical Co., Ltd. (Stock Code: 1752) announced its Q1 2026 financial results, reporting an EPS of 0.32 NTD, operating revenue of 530 million NTD, and net profit of 32 million NTD, indicating steady performance in the biotechnology and medical sector.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 9, 2026 at 08:00 (1655h 0m after Published)
- 🤖 AI Analyzed: May 9, 2026 at 08:34 (34 min after Collected)
Company Code: 1752
Company Name: Nang Kwong Chemo-Pharmaceutical Co., Ltd.
Industry: Biotechnology and Medical
Period: 2026 Q1
Basic Earnings Per Share: 0.32 NTD
Operating Revenue: 530 million NTD
Net Profit After Tax: 32 million NTD
Company Name: Nang Kwong Chemo-Pharmaceutical Co., Ltd.
Industry: Biotechnology and Medical
Period: 2026 Q1
Basic Earnings Per Share: 0.32 NTD
Operating Revenue: 530 million NTD
Net Profit After Tax: 32 million NTD